Effect of PEGylation on the solution conformation of antibody fragments

被引:50
作者
Lu, Yanling [1 ]
Harding, Stephen E. [1 ]
Turner, Alison [2 ]
Smith, Bryan [2 ]
Athwal, Diljeet S. [2 ]
Grossmann, J. Guenter [3 ]
Davis, Kenneth G. [1 ]
Rowe, Arthur J. [1 ]
机构
[1] Univ Nottingham, Natl Ctr Macromol Hydrodynam, Loughborough LE12 5RD, England
[2] UCB Celltech, Slough SL1 1NH, Berks, England
[3] Synchrotron Radiat Dept, CCLRC Daresbury Lab, Warrington WA4 4AD, Cheshire, England
基金
英国工程与自然科学研究理事会;
关键词
PEGylation; immunoglobulin; antibody fragment; conformation;
D O I
10.1002/jps.21170
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Covalent attachment of poly(ethylene glycol) (PEG) to therapeutic antibody fragments has been found effective in prolonging the half-life of the protein molecule in vivo. In this study analytical ultracentrifugation (AUC) in combination with small angle X-ray scattering (SAXS) has been applied to a number of antibody fragments and to their respective PEGylated conjugates. Despite the large increase in molecular weight due to the attachment of a 20-40 kDa PEG moiety, the PEGylated conjugates have smaller sedimentation coefficients, s, than their parent antibody fragments, due to a significant increase in frictional ratio f/f(o) (from similar to 1.3 to 2.3-2.8): the solution hydrodynamic properties of the conjugates are clearly dominated by the PEG moiety (f/f(o) similar to 3.0). This observation is reinforced by SAXS data at high values of r (separation of scattering centres within a particle) that appear dominated by the PEG part of the complex. By contrast, SAXS data at low values of r suggest that there are no significant conformational changes of the protein moiety itself after PEGylation The location of the PEGylation site within the conjugate was identified, and found to be consistent with expectation from the conjugation chemistry. 0 2007 Wiley-Liss, Inc. and the American Pharmacists Association.
引用
收藏
页码:2062 / 2079
页数:18
相关论文
共 65 条
[1]  
BAILEY F., 1959, J APPL POLYM SCI, V1, P56, DOI DOI 10.1002/APP.]959.070010110
[2]   Polyethylene glycol-conjugated pharmaceutical proteins [J].
Bailon, P ;
Berthold, W .
PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY, 1998, 1 (08) :352-356
[3]   DATA ACQUISITION-SYSTEMS FOR LINEAR AND AREA X-RAY-DETECTORS USING DELAY-LINE READOUT [J].
BOULIN, CJ ;
KEMPF, R ;
GABRIEL, A ;
KOCH, MHJ .
NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT, 1988, 269 (01) :312-320
[4]   Study of conformational properties of poly(ethylene oxide) by SANS and PCS techniques [J].
Branca, C ;
Magazù, S ;
Maisano, G ;
Migliardo, F ;
Migliardo, P ;
Romeo, G .
PHYSICA SCRIPTA, 2003, 67 (06) :551-554
[5]   Hydration parameters of aqueous solutions of poly(ethylene glycol)s by viscosity data [J].
Branca, C ;
Magazù, S ;
Maisano, G ;
Migliardo, P ;
Migliardo, F ;
Romeo, G .
PHYSICA SCRIPTA, 2002, 66 (02) :175-179
[6]   Novel size-independent modeling of the dilute solution conformation of the immunoglobulin IgG Fab′ domain using SOLPRO and ELLIPS [J].
Carrasco, B ;
de la Torre, JG ;
Byron, O ;
King, D ;
Walters, C ;
Jones, S ;
Harding, SE .
BIOPHYSICAL JOURNAL, 1999, 77 (06) :2902-2910
[7]   HIGH-LEVEL ESCHERICHIA-COLI EXPRESSION AND PRODUCTION OF A BIVALENT HUMANIZED ANTIBODY FRAGMENT [J].
CARTER, P ;
KELLEY, RF ;
RODRIGUES, ML ;
SNEDECOR, B ;
COVARRUBIAS, M ;
VELLIGAN, MD ;
WONG, WLT ;
ROWLAND, AM ;
KOTTS, CE ;
CARVER, ME ;
YANG, M ;
BOURELL, JH ;
SHEPARD, HM ;
HENNER, D .
BIO-TECHNOLOGY, 1992, 10 (02) :163-167
[8]   Preparation, characterisation and tumour targeting of cross-linked divalent and trivalent anti-tumour Fab' fragments [J].
Casey, JL ;
King, DJ ;
Chaplin, LC ;
Haines, AMR ;
Pedley, RB ;
Mountain, A ;
Yarranton, GT ;
Begent, RHJ .
BRITISH JOURNAL OF CANCER, 1996, 74 (09) :1397-1405
[9]   Therapeutic antibody fragments with prolonged in vivo half-lives [J].
Chapman, AP ;
Antoniw, P ;
Spitali, M ;
West, S ;
Stephens, S ;
King, DJ .
NATURE BIOTECHNOLOGY, 1999, 17 (08) :780-783
[10]   PEGylated antibodies and antibody fragments for improved therapy: a review [J].
Chapman, AP .
ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (04) :531-545